Ongoing Studies
Ongoing Clinical Trials
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial
https://www.bmj.com/content/375/bmj.n2635
https://www.bmj.com/content/bmj/375/bmj.n2635.full.pdf
https://web.archive.org/web/20211102150916/https://www.bmj.com/content/bmj/375/bmj.n2635.full.pdf
"Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals"
https://clinicaltrials.gov/ct2/show/NCT04368728
"Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)"
https://clinicaltrials.gov/ct2/show/NCT04283461
Pfizer Phase 3 Trials Estimated Study Completion Date: May 15, 2023
https://clinicaltrials.gov/ct2/show/NCT04368728
Moderna Phase 3 Trials Estimated Study Completion Date: October 27, 2022
https://clinicaltrials.gov/ct2/show/NCT04470427
Johnson & Johnson Phase 3 Trials Estimated Study Completion Date: January 2, 2023
https://clinicaltrials.gov/ct2/show/NCT04505722
AstraZeneca Phase 3 Trials Estimated Study Completion Date: February 14, 2023
https://clinicaltrials.gov/ct2/show/NCT04516746
Pfizer's website says it needs at least 3 years to get to Phase 3 trials.
https://www.pfizer.com/science/clinical-trials/guide-to-clinical-trials/phases
